Neuroscientists have long been intrigued by the pervasive slow waves observed during cortical sleep, which serve as hallmarks of sleep need and homeostatic regulation in the brain. These slow waves reflect a state of cortical disconnection from the external environment, facilitating critical restorative processes. However, the extent to which analogous processes occur in subcortical structures, particularly the hippocampus—a region integral to memory consolidation—remained obscure until now.

Capitalizing on the high spatial and temporal resolution of Neuropixels probes, the investigative team embarked on an ambitious recording campaign, capturing hippocampal electrophysiological activity spanning complete sleep/wake cycles in freely moving rats. This expansive dataset illuminated the nuanced patterns of hippocampal sharp waves (SPWs) and associated phenomena, including ripples and dentate spikes (DSs), intricately linked with the organism’s sleep need.

Intriguingly, unlike the canonical cortical slow waves strictly confined to sleep phases, hippocampal SPWs manifested robustly not only during behavioral sleep but also during periods of quiet wakefulness. This observation is particularly striking, suggesting that the hippocampus navigates a partially disconnected state even while the cortex ostensibly remains awake and aware. This unique hippocampal mode challenges prevailing paradigms of brain-wide sleep-wake dichotomies and hints at region-specific sleep microstates.

Quantitative analyses revealed a salient negative correlation between the expression of hippocampal SPWs, ripples, and DSs during cortical wakefulness and their occurrence during subsequent cortical sleep episodes. This inverse relationship implies that hippocampal sharp-wave events may serve homeostatic functions akin to those traditionally attributed to cortical slow waves, potentially providing regulatory mechanisms to equilibrate neuronal excitability and synaptic plasticity across vigilance states.

The electrophysiological signature accompanying hippocampal SPWs showcased an elevated slow-to-fast gamma oscillation ratio, consistent with a functional switch towards a partially disconnected state. Gamma oscillations have long been associated with cognitive processing and network communication; thus, this shift underscores a modulation of hippocampal network dynamics that transcends simplistic binary sleep-wake classifications.

Collectively, these findings compel a conceptual reframing of hippocampal activity patterns, prompting the proposal of a discrete hippocampal ‘sharp-wave sleep’ state. This state embodies a unitary mode of operation characterized by transient disconnection yet sustained homeostatic regulation, decoupling the hippocampal sleep microarchitecture from that of the cortex.

The implications of delineating this hippocampal sharp-wave sleep extend far beyond basic neuroscience. Given the hippocampus’s pivotal role in memory consolidation, learning, and spatial navigation, uncovering its unique sleep modalities offers fertile ground for re-examining how memory traces are processed and integrated during rest. The dissociation between hippocampal and cortical sleep states invites hypotheses about parallel or complementary processing streams operating concurrently yet independently.

Moreover, the identification that hippocampal SPWs occur during quiet wakefulness posits a mechanistic substrate for offline processing and memory replay outside classical sleep episodes. This insight may inform novel therapeutic approaches targeting hippocampal function to ameliorate cognitive impairments associated with sleep disorders or neurodegenerative diseases.

Methodologically, the use of Neuropixels probes represents a powerful technological leap, permitting simultaneous, high-resolution sampling of thousands of neurons across multiple brain areas. This approach enables unprecedented dissection of temporal and spatial dynamics underlying complex brain states, as exemplified by the current study’s ability to capture subtle hippocampal electrophysiological signatures over extended periods without interrupting natural behavior.

This study also propels forward a broader conceptual framework regarding brain state heterogeneity. Rather than viewing sleep and wakefulness as rigidly demarcated, globally uniform brain states, it advocates for recognition of localized, perhaps functionally specialized, sub-states. Such nuanced understanding aligns with emerging evidence of regional sleep phenomena, including local cortical sleep and hippocampal replay during wakefulness, reshaping theories of consciousness and brain function.

The discovery also invites questions about the molecular and cellular substrates governing the hippocampal sharp-wave sleep state. Future research might explore neurotransmitter systems, neuromodulatory influences, and intracircuit mechanisms that enable the hippocampus to transiently disengage partially while maintaining homeostasis. Understanding these pathways could unlock new targets for manipulating sleep stages for therapeutic benefit.

Importantly, the concept of hippocampal sharp-wave sleep may dovetail with existing hypotheses on sleep’s role in synaptic homeostasis and memory optimization. Given the hippocampus’s role in encoding episodic information, the ability to switch momentarily into a homeostatically regulated disconnected mode could represent a critical phase during which synaptic strength is selectively adjusted, and neural circuits are optimized.

The divergence in gamma oscillatory activity during hippocampal SPWs compared to cortical slow waves also beckons electrophysiological investigations into how oscillatory hierarchies interact across regions during sleep. These dynamics might influence how information flows through cortico-hippocampal circuits and orchestrate the timing of memory consolidation processes.

By defining a novel, partially disconnected hippocampal state dissociable from cortical sleep, this research opens new vistas into the architecture of sleep and brain function. It underscores the imperative of multi-regional, high-resolution recordings in unraveling the complex mosaic of brain states that facilitate cognition, memory, and homeostatic maintenance.

In conclusion, the identification of hippocampal sharp-wave sleep represents a paradigm shift in our understanding of sleep neurobiology. It reveals the hippocampus not merely as a passive recipient of cortical rhythms but as an active, autonomous generator of specialized sleep-like states. This revelation holds profound implications for neuroscience, medicine, and the fundamental biology of sleep, heralding a new chapter in the quest to decipher the mysteries of the sleeping brain.

Subject of Research: Hippocampal activity patterns during sleep and wakefulness, with emphasis on sharp waves, ripples, and dentate spikes, and their relation to sleep need and homeostatic regulation beyond cortical slow-wave sleep.

Article Title: A hippocampal ‘sharp-wave sleep’ state that is dissociable from cortical sleep

Article References:
Findlay, G., Cavelli, M.L., Bugnon, T. et al. A hippocampal ‘sharp-wave sleep’ state that is dissociable from cortical sleep. Nat Neurosci (2025). https://doi.org/10.1038/s41593-025-02141-8

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41593-025-02141-8

Benzodiazepines and related compounds, commonly prescribed for insomnia and anxiety, have long been favored for their sedative properties. However, despite their affordability and widespread availability—particularly in regions like Quebec—their long-term use raises serious concerns. These drugs are not only addictive but also carry risks of severe withdrawal symptoms, which include increased incidence of falls, hospitalizations, and cognitive impairments. The crucial question, which this new research seeks to answer, is how these medications affect the underlying neurophysiological aspects of sleep, especially in older populations who are more vulnerable to both insomnia and cognitive decline.

The study involved a detailed assessment of 101 individuals aged between 55 and 80. Participants were classified into three distinct groups: good sleepers without insomnia, individuals with chronic insomnia but no benzodiazepine use, and those with chronic insomnia who had been using benzodiazepine or BZRA drugs at least three times per week for over three months. By employing overnight polysomnography—a gold standard sleep assessment methodology—the researchers quantified not only the macrostructure of sleep but also analyzed brainwave activities and specific electrophysiological oscillations, including slow waves and sleep spindles, both known to play critical roles in memory consolidation and general brain health.

One of the study’s pivotal revelations concerns the reduction in the amount of deep sleep stages—also known as slow-wave sleep—in benzodiazepine/BZRA users compared to insomniacs not using these medications. Slow-wave sleep is characterized by synchronous, slow-frequency brain oscillations, alongside vital physiological changes such as reduced heart rate and slowed respiration. These stages are fundamental for the brain’s ability to consolidate newly acquired information, integrate memories, and perform restorative processes. The attenuation of this deep sleep thus suggests a mechanistic basis for cognitive impairments often observed among chronic users.

Moreover, the research highlighted disruptions in the coupling of brain oscillations among the benzodiazepine/BZRA cohort. Normally, sleep involves a dynamic interplay between different oscillatory activities—such as the synchronized timing between slow waves and sleep spindles—to optimize cognitive processing during rest. The observed decoupling in users implies a breakdown in this crucial neural synchronization, potentially leading to impaired information processing and memory consolidation. This finding underscores the subtle yet profound neurophysiological consequences of long-term sedative usage beyond mere alterations in sleep duration or latency.

Intriguingly, the degree of sleep disturbance correlated with the dosage of benzodiazepines taken. Participants with higher dosages experienced longer latency to fall asleep and delays in reaching restorative deep sleep stages. Such dose-dependent effects imply that not only the presence but also the intensity of benzodiazepine exposure critically modulates the extent of sleep architecture disruption, highlighting a pressing need for dosage monitoring and cautious prescription practices particularly in elderly populations.

The implications of these findings extend beyond basic sleep science to clinical practice. As Loïc Barbaux, the study’s lead author, emphasizes, the degradation of sleep architecture and brain oscillatory robustness may provide a biological explanation for the cognitive decline and functional impairments previously linked to these medications, compounding the natural deterioration seen in aging individuals. This underscores the paradox of sedative use: medications intended to alleviate insomnia symptoms may in fact exacerbate underlying cognitive vulnerabilities.

Despite these risks, benzodiazepines remain in common use for managing anxiety and short-term insomnia, especially among younger adults where the safety profile is considered relatively favorable for brief treatment periods. Yet, for older adults, this study lends further weight to existing recommendations by entities such as the American Geriatrics Society, which advises against benzodiazepine use in individuals over the age of 65 due to heightened risks.

For older adults currently dependent on these medications, the researchers advocate a carefully supervised, gradual tapering approach. Sudden cessation can induce rebound insomnia—a pronounced exacerbation of sleep disturbances—and other serious withdrawal symptoms. Coupling this taper with cognitive behavioral therapy for insomnia (CBT-I) improves the likelihood of successful discontinuation while enhancing sleep quality through non-pharmacological means.

The study’s authors also call upon healthcare systems and policymakers to prioritize the development and accessibility of safer, evidence-based insomnia treatments that do not rely on chronic sedative use. Psychological interventions, lifestyle modifications, and emerging pharmacotherapies offer promising alternatives that mitigate risks and preserve cognitive function in aging populations.

In conclusion, this landmark research not only challenges the safety and efficacy of long-term benzodiazepine and BZRA use in older adults but also charts a path forward for improving sleep health and cognitive resilience in this vulnerable demographic. As our understanding of sleep’s neurophysiology deepens, so too must our commitment to evidence-based, patient-centered approaches that safeguard brain health across the lifespan.

Subject of Research: People
Article Title: Effect of chronic benzodiazepine and benzodiazepine receptor agonist use on sleep architecture and brain oscillations in older adults with chronic insomnia
News Publication Date: 17-Jun-2025
Web References:

• https://academic.oup.com/sleep/advance-article/doi/10.1093/sleep/zsaf168/8164643
• https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.18372
• https://www.concordia.ca/faculty/thanh-dang-vu.html
  References:
  Dang-Vu, T., Barbaux, L., et al. (2025). Effect of chronic benzodiazepine and benzodiazepine receptor agonist use on sleep architecture and brain oscillations in older adults with chronic insomnia. Sleep. DOI: 10.1093/sleep/zsaf168
  Image Credits: Concordia University
  Keywords: Sleep disorders, Insomnia, EEG activity, Sleep deprivation, Slow wave sleep, REM sleep, Adults, Aging populations

The spectrum of research presented encompasses urgent questions regarding the physiological mechanisms underlying sleep and its disruption. A notable presentation by Dr. Andrew W. Varga addressed whether the failure of the brain’s cleaning processes during sleep—critical to the brain’s waste clearance through the glymphatic system—is a causal factor in Alzheimer’s disease. By dissecting the complex interaction between sleep architecture and cerebral proteostasis, this work provides novel insights into potential therapeutic targets for neurodegeneration.

On another front, Dr. Emmanuel During focused on biomarker updates related to REM Sleep Behavior Disorder (RBD), leveraging neurophysiology, actigraphy, and biofluid markers. Their work highlights how robust multimodal biomarker identification can facilitate earlier and more precise diagnosis of RBD, a condition with profound links to synucleinopathies such as Parkinson’s disease and dementia with Lewy bodies. This approach dovetails with computational advancements utilizing actigraphy-based classifiers, aiming for non-invasive, scalable screening.

Investigations into sleep apnea’s impact on neurodegeneration were featured prominently. Drs. Korey Kam and Anna Mullins discussed the differential effects obstructive sleep apnea (OSA) exerts on Alzheimer’s pathogenesis, emphasizing physiological, racial, and sex-specific mechanisms. Their symposium underscored how OSA’s intermittent hypoxia and sleep fragmentation may accelerate neurodegenerative cascades, with critical variance influenced by demographic factors.

Several poster presentations delved into the intersection between sleep physiology and cognitive function across lifespan and disease states. For instance, Anjona Datta and Daphne Valencia examined the influence of REM-specific OSA and hypoxic burden on sleep-dependent spatial navigational memory and white matter integrity in cognitively normal elderly adults. Their use of diffusion tensor imaging (DTI) elucidates microstructural brain alterations that may underlie cognitive decline linked to sleep-disordered breathing.

Furthermore, research by Anna Mullins explored how encoding opportunities and slow wave activity during sleep modulate spatial memory consolidation in older adults. This study tackles the decline in sleep microstructure with age, proposing that amplified encoding before sleep can mitigate cognitive deterioration effects, a finding with profound implications for interventions in aging populations.

Animal model research by Kerly Lozano investigated early adult sleep disruption in PS19 tauopathy mice, tracking longitudinal changes in spatial learning, neuroinflammation, and tau pathology. This translational work strengthens the mechanistic understanding of how sleep deficiencies influence tau-mediated neurodegeneration, bolstering arguments for prioritizing sleep health in Alzheimer’s disease prevention.

On the technology and methodology front, Benjamin Fox and Sajila Wickramaratne presented the creation of a Transformer-based machine learning model that processes full-night multichannel polysomnographic data to predict cardiovascular mortality risk. This innovation represents a leap forward in detecting cardiometabolic risks rooted in sleep disorders, illustrating the confluence of artificial intelligence and biomedical data for predictive healthcare.

Automated scoring techniques were critically evaluated in studies such as Dr. Thomas Tolbert’s comparison of automated versus manual arousal threshold estimation using polysomnography. Automated methods based on EEG power enhance phenotyping accuracy and efficiency in OSA endotyping, potentially transforming clinical sleep diagnostics.

Exploring demographic nuances, Sarah Chu analyzed physiological burdens of OSA across diverse populations from the Sleep Heart Health Study and Multi-Ethnic Study of Atherosclerosis. She revealed how emerging respiratory metrics vary with age, sex, and race/ethnicity, underscoring the necessity for tailored diagnostic criteria and personalized treatment strategies.

Additional studies investigated the locus coeruleus structural integrity in older adults with OSA through ultra-high field 7 Tesla MRI, linking sleep apnea to neurodegeneration markers in this crucial brainstem region involved in arousal regulation. Such neuroimaging advances provide unprecedented resolution to examine subtle pathological changes early in disease progression.

Efforts to validate non-invasive sleep monitoring tools were also emphasized, as shown by Daphne Valencia’s assessment of the WatchPAT device’s diagnostic accuracy against concurrent polysomnography in older adults—a critical step toward accessible, community-based sleep disorder assessments.

Sleep irregularity’s connections to cardiometabolic health were dissected by Bolong Xu using actigraphy and PET/MRI imaging, revealing associations between disrupted sleep patterns and vascular inflammation independent of OSA, highlighting novel pathways by which sleep disturbances contribute to cardiovascular disease.

Mount Sinai researchers also spotlighted specialized populations, including World Trade Center rescue workers, with studies linking chronic rhinosinusitis to insomnia symptoms and cognitive impairment, echoing the importance of addressing comorbidities influencing sleep in vulnerable groups.

In the evolving landscape of sleep disorder assessments, Dr. Emmanuel During’s late-breaking research includes developing automated RBD severity rating with computer vision and machine learning classifiers for prodromal synucleinopathy screening, offering scalable solutions for early intervention in neurodegenerative diseases.

Taken together, Mount Sinai’s presentations at SLEEP 2025 represent a comprehensive, multi-disciplinary assault on the mysteries of sleep and its far-reaching effects on neurological and systemic health. Integrating advanced imaging, neurophysiology, bioinformatics, and clinical insights, these studies pave the way toward diagnostic and therapeutic innovations targeting sleep as a pillar of wellness and disease prevention.

Subject of Research: Sleep physiology, neurodegenerative diseases, obstructive sleep apnea, biomarkers, machine learning in sleep medicine.

Article Title: Sleep Medicine Breakthroughs from Mount Sinai Experts Revealed at SLEEP 2025 Conference

News Publication Date: June 8, 2025

Web References:

• https://www.sleepmeeting.org
• https://academic.oup.com/sleep/article/48/Supplement_1

Image Credits: The Mount Sinai Health System

Keywords: Sleep, REM sleep, Sleep deprivation, Neurodegenerative diseases, Alzheimer disease, Parkinson’s disease, Cognitive disorders, Dementia, Sleep apnea